化合物BRL 50481 T5106
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 433695-36-4 | ¥389.00 | 询底价 |
10 mg | 433695-36-4 | ¥521.00 | 询底价 |
25 mg | 433695-36-4 | ¥997.00 | 询底价 |
100 mg | 433695-36-4 | ¥2,995.00 | 询底价 |
50 mg | 433695-36-4 | ¥1,843.00 | 询底价 |
Product Introduction
Bioactivity
英文名: BRL-50481
描述: BRL 50481 是一种新型的、选择性的 PDE7 的抑制剂,对 PDE7A,PDE7B,PDE4和 PDE3的 IC50值分别为 0.15,12.1,62 和 490 μM。
细胞实验: MOLT-4 cells in 96-well plates are treated for 30 min with BRL-50481. The cAMP content is then determined by an immuno-specific ELISA. Results are expressed as a percentage of the response affected by 100 μM IBMX[2].
体外活性: BRL-50481 increases the cAMP content (19.1±6.2% of IBMX response at 300 μM) but is considerably less potent. BRL-50481 (30 μM) fails to suppress proliferation by itself but significantly potentiates the effect of rolipram. BRL-50481 (30 μM) has no effect on IL-15-induced proliferation but augments the inhibitory effect of rolipram. Pretreatment (30 min) of human monocytes with BRL-50481 has, by itself, a negligible (~2 to 10%) inhibitory effect on TNFα output at all concentrations tested. BRL-50481 also potentiates the inhibitory effect of PGE2 on LPS-induced TNFα release. BRL-50481 has no significant effect by itself on κB-dependent transcription (5.6±1.9% inhibition at 30 μM) and fails to enhance the effect of rolipram (maximum inhibition, 52.9±2.7%; pIC30 value of 5.33±0.12). BRL-50481 suppresses, in a concentration-dependent manner, LPS-induced TNFα release in monocytes in which PDE7A1 is induced (21.7±1.6% inhibition at 30 μM at the 12-h time point) [2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: Ethanol : 20 mg/mL
DMSO : 45 mg/mL (184.22 mM)
关键字: BRL-50481 | inhibit | BRL50481 | Inhibitor | BRL 50481 | Phosphodiesterase (PDE)
相关产品: Torbafylline | Zatolmilast | PDE IV-IN-1 | BAY 2666605 | MR-L2 | Dasantafil | CALP2 acetate(261969-04-4 free base) | Ro 20-1724 | Theophylline monohydrate | Rolipram
相关库: Anti-Neurodegenerative Disease Compound Library | Bioactive Lipid Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Highly Selective Inhibitor Library | Metabolism Compound Library | Anti-Alzheimer's Disease Compound Library | Anti-Cardiovascular Disease Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物BRL 50481 T5106信息由TargetMol中国为您提供,如您想了解更多关于化合物BRL 50481 T5106报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途